• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2007 Agency for Healthcare Research and Quality (AHRQ) Screening for chlamydial infection: a focused evidence update for the U.S. Preventive Services Task Force
2007 Agency for Healthcare Research and Quality (AHRQ) Screening for human immunodeficiency virus: focused update of a 2005 systematic evidence review for the U.S. Preventive Services Task Force
2007 NIHR Health Technology Assessment programme The effectiveness and cost-effectiveness of natalizumab for multiple sclerosis: an evidence review of the submission from Biogen
2007 Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Effectiveness and safety of positron emission tomography in breast cancer]
2007 Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Bilateral cochlear implants in children: effectiveness, safety and cost. Situation in the Spanish regions]
2007 Adelaide Health Technology Assessment (AHTA) Genetic Screening for hypertrophic cardiomyopathy
2007 Adelaide Health Technology Assessment (AHTA) Bladderchek: diagnostic test for bladder cancer
2007 Adelaide Health Technology Assessment (AHTA) Vertebral assessment with DEXA
2007 Adelaide Health Technology Assessment (AHTA) Point-of-care influenza tests
2007 Adelaide Health Technology Assessment (AHTA) Niobe magnetic navigation system for percutaneous coronary interventions
2007 Adelaide Health Technology Assessment (AHTA) Affymetrix DNA microarrays
2007 Adelaide Health Technology Assessment (AHTA) Brahms PCT assays for the diagnosis of systemic bacterial infection
2007 Adelaide Health Technology Assessment (AHTA) VNS therapy system for the treatment of depression
2007 Adelaide Health Technology Assessment (AHTA) Earpopper™ for the treatment of otitis media in children
2007 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Dasatinib (Sprycel®) for the treatment of Lymphoid blast CML and PH+ ALL
2007 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Dasatinib (Sprycel®) for the treatment of chronic, accelerated or blast phase chronic myeloid leukaemia
2007 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Vinorelbine (Navelbine Oral®)
2007 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Idursulfase (Elaprase®)
2007 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Agalsidase alfa (Replagal®)
2007 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Sunitinib (Sutent®)
2007 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Darunavir (Prezista®)
2007 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tipranavir (Aptivus®)
2007 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Co-careldopa intestinal gel (Duodopa®)
2007 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Dexrazoxane (Savene®)
2007 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Clofarabine (Evoltra®)
2007 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Emtricitabine (Emtriva®)
2007 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Emtricitabine/tenofovir DF (Truvada®)
2007 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Parathyroid hormone (PTH) (Preotact®)
2007 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Use of sorafenib (Nexavar®) for advanced renal cell carcinoma within NHS Wales
2007 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Use of alglucosidase alfa (Myozyme™) within NHS Wales
2007 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Use of sodium phenylbutyrate within NHS Wales
2007 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Laronidase (Aldurazyme®)
2007 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Enfuvirtide
2007 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Anagrelide (Xagrid®)
2007 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Use of iloprost trometamol (Ventavis®) within NHS Wales
2007 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Interdisciplinary follow-up with actors in primary health care]
2007 Health Technology and Policy Unit (HTPU) Double Balloon Endoscopy/Enteroscopy (DBE) for the diagnosis and treatment of conditions of the small intestine
2007 Health Technology and Policy Unit (HTPU) Photoselective vaporization of the prostate (PVP) for the treatment of benign prostatic hyperplasia (BPH)
2007 Adelaide Health Technology Assessment (AHTA) Implantable miniature telescope for macular degeneration
2007 Adelaide Health Technology Assessment (AHTA) Magnetic resonance imaging for the detection of foetal abnormalities
2007 Basque Office for Health Technology Assessment (OSTEBA) [Clinical practice guideline on low back pain]
2007 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Exenatide in diabetes mellitus type 2 - Rapid report]
2007 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Hyperbaric oxygen therapy for burns]
2007 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Evidence-based patient information on chronic obstructive airway diseases - Asthma]
2007 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Expertise on endometriosis]
2007 Canary Health Service [Cost-effectiveness analysis and health outcomes in orthopedic surgery of the hip and knee]
2007 Canary Health Service [Dynamometry and simultaneous surface electromyography in the identification of nonspecific low back pain and its reliability]
2007 National Institute for Health and Care Excellence (NICE) Thoracoscopically assisted mitral valve surgery. NICE interventional procedures guidance 245
2007 National Institute for Health and Care Excellence (NICE) Hybrid procedure for interim management of hypoplastic left heart syndrome in neonates. NICE interventional procedures guidance 246
2007 National Institute for Health and Care Excellence (NICE) Thoracoscopic excision of mediastinal parathyroid tumours. NICE interventional procedures guidance 247
2007 National Institute for Health and Care Excellence (NICE) Thoracoscopic aortopexy for severe primary tracheomalacia. NICE interventional procedures guidance 243
2007 National Institute for Health and Care Excellence (NICE) Grenz rays therapy for inflammatory skin conditions. NICE interventional procedures guidance 236
2007 National Institute for Health and Care Excellence (NICE) Mini/micro screw implantation for orthodontic anchorage. NICE interventional procedures guidance 238
2007 National Institute for Health and Care Excellence (NICE) Laparoscopic techniques for hysterectomy. NICE interventional procedures guidance 239
2007 National Institute for Health and Care Excellence (NICE) Soft-palate implants for simple snoring. NICE interventional procedures guidance 240
2007 National Institute for Health and Care Excellence (NICE) Soft-palate implants for obstructive sleep apnoea. NICE interventional procedures guidance 241
2007 National Institute for Health and Care Excellence (NICE) Laparoscopic uterine nerve ablation (LUNA) for chronic pelvic pain. NICE interventional procedures guidance 234
2007 National Institute for Health and Care Excellence (NICE) Serial transverse enteroplasty procedure (STEP) for bowel lengthening in parenteral nutrition-dependent children. NICE interventional procedures guidance 232
2007 National Institute for Health and Care Excellence (NICE) Laparoscopic repair of abdominal aortic aneurysm. NICE interventional procedures guidance 229
2007 National Institute for Health and Care Excellence (NICE) Arthroscopic knee washout, with or without debridement, for the treatment of osteoarthritis. NICE interventional procedures guidance 230
2007 National Institute for Health and Care Excellence (NICE) Therapeutic percutaneous image-guided aspiration of spinal cysts. NICE interventional procedures guidance 223
2007 National Institute for Health and Care Excellence (NICE) Laparoscopic deroofing of simple renal cysts. NICE interventional procedures guidance 226
2007 National Institute for Health and Care Excellence (NICE) Corneal implants for keratoconus. NICE interventional procedures guidance 227
2007 National Institute for Health and Care Excellence (NICE) Corneal implants for the correction of refractive error. NICE interventional procedures guidance 225
2007 National Institute for Health and Care Excellence (NICE) Endoscopic augmentation of the lower oesophageal sphincter using hydrogel implants for the treatment of gastro-oesophageal reflux disease. NICE interventional procedures guidance 222
2007 National Institute for Health and Care Excellence (NICE) Therapeutic sialendoscopy. NICE interventional procedures guidance 218
2007 National Institute for Health and Care Excellence (NICE) Lower limb deep vein valve reconstruction for chronic deep venous incompetence. NICE interventional procedures guidance 219
2007 National Institute for Health and Care Excellence (NICE) Tissue-cultured limbal stem cell allograft transplantation for regrowth of corneal epithelium. NICE interventional procedures guidance 216
2007 National Institute for Health and Care Excellence (NICE) Laparoscopic nephrolithotomy and pyelolithotomy. NICE interventional procedures guidance 212
2007 National Institute for Health and Care Excellence (NICE) Microwave ablation of hepatocellular carcinoma. NICE interventional procedures guidance 214
2007 National Institute for Health and Care Excellence (NICE) Radiofrequency-assisted liver resection. NICE interventional procedures guidance 211
2007 National Institute for Health and Care Excellence (NICE) Laparoscopic insertion of peritoneal dialysis catheter. NICE interventional procedures guidance 208
2007 National Institute for Health and Care Excellence (NICE) Implantation of accommodating intraocular lenses for cataract. NICE interventional procedures guidance 209
2007 National Institute for Health and Care Excellence (NICE) Injectable bulking agents for faecal incontinence. NICE interventional procedures guidance 210
2007 National Institute for Health and Care Excellence (NICE) Laparoscopic distal pancreatectomy. NICE interventional procedures guidance 204
2007 National Institute for Health and Care Excellence (NICE) Fetal cystoscopy for the diagnosis and treatment of lower urinary outflow tract obstruction. NICE interventional procedures guidance 205
2007 National Institute for Health and Care Excellence (NICE) Palliative photodynamic therapy for advanced oesophageal cancer. NICE interventional procedures guidance 206
2007 Canary Health Service [Decision-making aid tools for patients with benign prostatic hyperplasia]
2007 Canary Health Service [Therapeutic interventions in the treatment of mental illness in children]
2007 Canary Health Service [Methodology for incorporating qualitative studies in health technology assessment]
2007 Canary Health Service [Systematic review and cost-effectiveness analysis of diabetic retinopathy screening with a 45º non-mydriatic retinograph using images interpreted by ophthalmologists versus family doctors]
2007 Canary Health Service [Safety, effectiveness and cost-effectiveness of simultaneous bilateral cataract surgery versus two-stage bilateral cataract surgery]
2007 Canary Health Service [Alternative systems to conventional Holter for the study of cardiac arrhythmias on an outpatient basis]
2007 Canary Health Service [Teleneurology vs. face-to-face consultation. Systematic review of their effectiveness and cost-effectiveness]
2007 National Institute for Health and Care Excellence (NICE) Inhaled corticosteroids for the treatment of chronic asthma in children under the age of 12 years. NICE technology appraisal guidance 131
2007 National Institute for Health and Care Excellence (NICE) Bortezomib monotherapy for relapsed multiple myeloma. NICE technology appraisal guidance 129
2007 National Institute for Health and Care Excellence (NICE) Stapled haemorrhoidopexy for the treatment of haemorrhoids. NICE technology appraisal guidance 128
2007 National Institute for Health and Care Excellence (NICE) Pemetrexed for the treatment of non-small-cell lung cancer. NICE technology appraisal guidance 124
2007 National Institute for Health and Care Excellence (NICE) Varenicline for smoking cessation. NICE technology appraisal guidance 123
2007 National Institute for Health and Care Excellence (NICE) Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma. NICE technology appraisal guidance 121
2007 National Institute for Health and Care Excellence (NICE) Fludarabine monotherapy for the first-line treatment of chronic lymphocytic leukaemia. NICE technology appraisal guidance 119
2007 National Institute for Health and Care Excellence (NICE) Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy. NICE technology appraisal guidance 117
2007 National Institute for Health and Care Excellence (NICE) Methadone and buprenorphine for the management of opioid dependence. NICE technology appraisal guidance 114
2007 National Institute for Health and Care Excellence (NICE) Naltrexone for the management of opioid dependence. NICE technology appraisal guidance 115
2007 National Institute for Health and Care Excellence (NICE) Gemcitabine for the treatment of metastatic breast cancer. NICE technology appraisal guidance 116